4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one PurCert Secondary Working Standard [Includes all characterization data]
CRM
Properties
| Assay Purity | >=95 % |
| Refractive index | n20/D 1.4760-1.4820 |
| B pt. | >90°C |
| Density | 1.362 g/cm3 |
| Form | Solid |
Safety Information
| Hazard Statement(s) | H302, H315, H319, H335 |
| Precautionary Statement | P261, P305, P338, P351 |
| GHS Pictogram |
|
| Signal word | Warning |
| HS Code | 29329990 |
| Flash point | 129 °C |
| Storage Temp. | Room Temperature |
| Storage Class | 10 - Combustible liquids |
Description
Application
It is widely used as a pharmaceutical intermediate and building block in the synthesis of medoxomil ester prodrugs and other active pharmaceutical ingredients.
Purpose
Its primary purpose is to introduce the medoxomil (cyclic carbonate) moiety into drug molecules to improve oral bioavailability and pharmacokinetic properties.
General Description
4-(Chloromethyl)-5-methyl-13-dioxol-2-one is a cyclic carbonate compound (CAS 80841-78-7 molecular formula C5H5ClO3) containing a reactive chloromethyl group that readily undergoes nucleophilic substitution reactions.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |